| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/24/2005 | US20050261223 Contacting the cell with a small inhibitory RNA (siRNA) that inhibits expression of a RIP140 polypeptide, thereby increasing glucose transport in the cell; eating disoders; metabolism; antidiabetic agents; brown fat |
| 11/24/2005 | US20050261187 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy |
| 11/24/2005 | US20050261183 PTHrP-derived modulators of smooth muscle proliferation |
| 11/24/2005 | US20050261179 Vasoregulating compounds and methods of their use |
| 11/24/2005 | US20050261165 compounds that inhibit activity of the AcrAB or AcrAB-like efflux pump are identified as compounds which reduce antibiotic resistance in a microbe that has 2 chromosomal mutations in a gene encoding an antibiotic target that renders it resistant and increased expression of at least one efflux pump |
| 11/24/2005 | US20050260770 Antigen array and diagnostic uses thereof |
| 11/24/2005 | US20050260769 Handheld medical logging apparatus and method |
| 11/24/2005 | US20050260766 Method for a fully automated monoclonal antibody-based extended differential |
| 11/24/2005 | US20050260743 Smart cell culture |
| 11/24/2005 | US20050260735 Method of decomposing protein with sulfonic acid compound |
| 11/24/2005 | US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 11/24/2005 | US20050260731 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 11/24/2005 | US20050260730 CDK2/cyclin A crystals and uses thereof |
| 11/24/2005 | US20050260709 Lipin1 function |
| 11/24/2005 | US20050260708 Proteases and protease inhibitors |
| 11/24/2005 | US20050260707 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 11/24/2005 | US20050260703 Biochemical blocking layer for liquid crystal assay |
| 11/24/2005 | US20050260698 Enzyme activation of amphiphiles; providing a dye precursor which contains an enzymatically cleavable group, cleaving of the dye precursor using an enzyme thereby forming the dye and binding of the dye to the membrane |
| 11/24/2005 | US20050260697 Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining |
| 11/24/2005 | US20050260696 Method for diagnosis of thrombotic disorders |
| 11/24/2005 | US20050260695 Methods, compositions, devices, and kits for detecting mastitis |
| 11/24/2005 | US20050260694 Modification of bioassays for detection of antigens characteristic of bacteria that are causative of ear and respiratory infections to eliminate false positive results caused by nasopharyngeal colonization of children |
| 11/24/2005 | US20050260693 Tumor suppressor gene |
| 11/24/2005 | US20050260692 Positive selection in the immuno-dominant surface antigen 1 (SAG1) of sarcocystis neurona, agent of EPM: potential as a diagnostic reagent and as a component of a sub-unit vaccine |
| 11/24/2005 | US20050260691 Serum biomarkers for Chagas disease |
| 11/24/2005 | US20050260690 Methods and materials for diagnosing unstable angina |
| 11/24/2005 | US20050260689 Differential immunoassay |
| 11/24/2005 | US20050260688 Methods and compositions for hair growth |
| 11/24/2005 | US20050260686 The particles are distinguishable from each other by characteristics that permit them to be differentiated into groups, each group carrying an assay reagent bonded to the particle surface that is distinct from the assay reagents of particles in other groups. |
| 11/24/2005 | US20050260685 Arrays of biological membranes and methods and use thereof |
| 11/24/2005 | US20050260684 Method and probes for the detection of a tumor specific fusion protein |
| 11/24/2005 | US20050260683 Methods for diagnosing and treating pre-term labor |
| 11/24/2005 | US20050260681 Recovering autoantibodies/blood protein via adjustment in redox states for use in constructing profile for diagnosing autoimmune disorders; immunotherapy; antioxidant |
| 11/24/2005 | US20050260680 Methods of diagnosing and treating autoimmune diseases |
| 11/24/2005 | US20050260679 Reducing the risk of human anti-human antibodies through V gene manipulation |
| 11/24/2005 | US20050260678 Method of diagnosing nephrotic syndrome |
| 11/24/2005 | US20050260677 The light adjusting portion receives the light produced by the light source module and provides light having a propagation angle that is constant to the assay sensing portion; used for bioassays for the detection of human pathogens and toxins in food, water, and the environment |
| 11/24/2005 | US20050260676 Precision fluorescently dyed particles and methods of making and using same |
| 11/24/2005 | US20050260671 Medical diagnosis or prognosis, analyzing toxicity or efficiency of drugs, by data processing or high throughput assay |
| 11/24/2005 | US20050260666 Lateral flow quantitative assay method and strip and laser-induced fluorescence detection device therefor |
| 11/24/2005 | US20050260663 Functional proteomics modeling system |
| 11/24/2005 | US20050260661 Assays for the identification of modulators of MHC class II expression |
| 11/24/2005 | US20050260660 Detecting two interacting agents in cell by binding antibody or nucleic acid using dyes and fluorescence resonance energy transfer |
| 11/24/2005 | US20050260658 Image-based method for detection and removal of small fragments in segmented three-dimensional volumes |
| 11/24/2005 | US20050260654 Neural proteins as biomarkers for nervous system injury and other neural disorders |
| 11/24/2005 | US20050260653 Nucleic-acid programmable protein arrays |
| 11/24/2005 | US20050260650 Alternatively spliced isoforms of interleukin-4 receptor subunit alpha (IL-4Ralpha) |
| 11/24/2005 | US20050260648 Method for the determination of cellular transcriptional |
| 11/24/2005 | US20050260647 Diagnosis of esophageal tumor by detecting expression of a specific polypeptidein a test sample from a patient, wherein lower expression of the polypeptide as compared to a normal control sample indicates the presence of esophageal tumor. |
| 11/24/2005 | US20050260644 Cell signaling proteins |
| 11/24/2005 | US20050260638 Methods for detecting nucleic acids indicative of cancer |
| 11/24/2005 | US20050260632 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260629 Differential drug sensitivity |
| 11/24/2005 | US20050260623 Oct-4 and GJIC expression as markers for adult human stem cells and cancer cell precursors |
| 11/24/2005 | US20050260622 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/24/2005 | US20050260617 Oligo-or polynucleotides |
| 11/24/2005 | US20050260615 System and process of determining a biological pathway based on a treatment of a biological specimen |
| 11/24/2005 | US20050260614 Methods for real-time single molecule sequence determination |
| 11/24/2005 | US20050260611 Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules |
| 11/24/2005 | US20050260610 Method for diagnosing and prescribing a regimen of therapy for human health risk |
| 11/24/2005 | US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof |
| 11/24/2005 | US20050260600 Amino radicals; magnetic bodies, metals, plastic and glass beads or gel; increased recovery ratio |
| 11/24/2005 | US20050260599 Nucleic acid and amino acid sequences of sweet taste receptors comprising two heterologous G-protein coupled receptor polypeptides; screening for modulators; probes for the identification of taste cells |
| 11/24/2005 | US20050260591 5T4 antigen expression |
| 11/24/2005 | US20050260582 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same |
| 11/24/2005 | US20050260581 Gonococcal proteins and nucleic acids |
| 11/24/2005 | US20050260580 Erythropoietin and erythropoietin receptor expression in human cancer |
| 11/24/2005 | US20050260579 TGF-beta type receptor cDNAs encoded products |
| 11/24/2005 | US20050260577 Detection of neurodegenerative disorders |
| 11/24/2005 | US20050260575 Method for identifying substances useful for treating inflammation using the response element to the ikbalpha ror receptor |
| 11/24/2005 | US20050260569 Method, device and system for detecting the presence of microorganisms |
| 11/24/2005 | US20050260568 Hepatitis C virus assays |
| 11/24/2005 | US20050260566 such as cervical cancer, independent of the patient's human papilloma virus (HPV) infection status by detecting biomarker(s) selectively overexpressed in high-grade cervical disease; immunocytochemistry or PCR; kits; biomarker such as Minichromosome maintenance (MCM) proteins |
| 11/24/2005 | US20050260565 contacting in vitro a sample comprising chemokine 88C receptor with a putative ligand, detecting binding of the 88C receptor and the putative ligand; increase in 88C signal transduction activity indicates the ligand is an activator, a decreasein transduction activity indicates the ligand is an inhibitor |
| 11/24/2005 | US20050260563 Methods for measurement of lymphocyte function |
| 11/24/2005 | US20050260559 Antiviral agent against picornavirus infections, the assayselects an agent that disrupts the association between picornavirus protein 2c and the host cell protein DAKAP2for viral replication |
| 11/24/2005 | US20050260558 Comparative phenotype analysis of cells including testing of biologically active chemicals |
| 11/24/2005 | US20050260557 Method of quantifying the cell-binding properties of a medical device |
| 11/24/2005 | US20050260556 Using f-box containing protein as tool in treatment and prevention of infection, cardiovascular, cell proliferative and nervous system disorders |
| 11/24/2005 | US20050260555 Chemosensitivity measurement using caspase activity |
| 11/24/2005 | US20050260507 Photolithographic method and system for efficient mask usage in manufacturing DNA arrays |
| 11/24/2005 | US20050260423 Modified microsurfaces and methods of their manufacture |
| 11/24/2005 | US20050260292 Sovent extraction of hemagglutinin specific for acetyl-D-galactosamine residues of O-glycosidically linked oligosaccharide of glycophorin A by homogenizing seeds with a homogenizing agent comprising phosphate-buffered saline and glycine;centrifuging and filtering to collect supernatant; antitumor agent |
| 11/24/2005 | US20050260234 Anti-neovasculature preparations for cancer |
| 11/24/2005 | US20050260224 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 11/24/2005 | US20050260221 Hepatitis C virus constructs characterized by high efficiency replication |
| 11/24/2005 | US20050260218 House dust mite allergen, Der f VII, and uses therefor |
| 11/24/2005 | US20050260212 Expressed in the stroma surrounding the cancer tumor, targeting the tumor stroma via anti-LFL2 therapy can decrease the tumor interstitial fluid pressure (IFP), resulting in greater blood flow to the tumor and more efficient chemotherapeutic drug delivery or delivery of other molecular therapy |
| 11/24/2005 | US20050260209 Ephrin-b receptor protein involved in carcinoma |
| 11/24/2005 | US20050260207 Monoclonal antibody neutralising cathepsin b activity and uses thereof |
| 11/24/2005 | US20050260200 Antigenic peptides reacting with anti-ovary antibodies |
| 11/24/2005 | US20050260197 Receptor for Oncostatin M |
| 11/24/2005 | US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents |
| 11/24/2005 | US20050260177 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 11/24/2005 | US20050260155 Compositions and methods for treatment of ulcerative colitis |
| 11/24/2005 | US20050260154 G-CSF analog compositions and methods |
| 11/24/2005 | US20050260135 High throughput pharmaceutical screening using drosophila |
| 11/24/2005 | US20050260133 Strategy for designing patient-specific anti-cancer drugs |
| 11/24/2005 | US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 11/24/2005 | US20050260124 Method of diagnosing risk of myocardial infarction |